正邦科技(002157.SZ)下屬子公司擬向鶴慶正邦增資2.4億元
格隆匯11月18日丨正邦科技(002157.SZ)公佈,公司於2019年11月18日召開第六屆董事會第二次臨時會議,審議通過了《關於對下屬子公司鶴慶正邦農牧有限公司增資的議案》。公司下屬子公司江西正邦養殖有限公司(“正邦養殖”)以自有資金出資2.4億元對鶴慶正邦農牧有限公司(“鶴慶正邦”)增資,增資後鶴慶正邦的註冊資本由1000萬元增加至2.5億元。
鶴慶正邦農牧有限公司經營範圍:種豬繁育、銷售,生豬養殖、銷售,飼料、有機肥加工、銷售,生豬養殖技術諮詢服務**(依法須經批准的項目,經相關部門批准後方可開展經營活動)
此次增資主要為促進鶴慶正邦的主業發展,提升整體經營實力及融資能力,為鶴慶正邦後續發展奠定基礎。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.